Profil bibliographique

Kevin C. De Braganca

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

86Publications signalées

2809Citations signalées

2Affiliations récentes

Institutions déclarées

Johnson & Johnson (United States)Johnson & Johnson (Israel)

Domaines associés

CAR-T cell therapy researchMultiple Myeloma Research and TreatmentsGlioma Diagnosis and TreatmentBiosimilars and Bioanalytical MethodsProtein Degradation and Inhibitors

Publications récentes

Accès ouvert 2026 articleOpenAlex

Non-ICANS Neurologic Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Ciltacabtagene Autoleucel: Clinical Presentation and Management in CARTITUDE Studies

Paula Rodríguez‐Otero, Jaime Gállego Pérez-Larraya, Yi Lin, Jorg Dietrich et autres

0 citationsClinical Lymphoma Myeloma & Leukemia

Accès ouvert 2026 articleOpenAlex

Real-World Description of Non-ICANS Neurologic Events Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Ciltacabtagene Autoleucel Using Two Large US Databases

Surbhi Sidana, Saurabh P. Nagar, Sabyasachi Ghosh, Lin Fan et autres

1 citationOncology and Therapy

Accès ouvert 2026 articleOpenAlex

Clinical outcomes with ciltacabtagene autoleucel among patients with relapsed/refractory multiple myeloma after four or more prior lines of therapy overall and among subgroups based on age, frailty, and CRAB symptoms

Doris K Hansen, Omar Castañeda Puglianini, Ariel Grajales‐Cruz, Saurabh P. Nagar et autres

1 citationCurrent Medical Research and Opinion

Accès ouvert 2025 articleOpenAlex

Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4

Paula Rodríguez‐Otero, Surbhi Sidana, Mathilde C.M. Kouwenhoven, Jordan M. Schecter et autres

7 citationsBlood Cancer Journal

Accès ouvert 2025 conference-abstractOpenAlex

Bridging therapy response and low pre-lymphodepletion plasma cell burden are associated with improved safety and efficacy outcomes of ciltacabtagene autoleucel in multiple myeloma

Doris Hansen, Brett M. Reid, Ariel Grajales‐Cruz, Peter K.C. Cheng et autres

5 citationsBlood

Accès ouvert 2025 conference-abstractOpenAlex

Single-cell immune profiling reveals enhanced immune fitness of endogenous and engineered T cells in patients with high-risk smoldering myeloma compared to Relapsed/Refractory myeloma following bispecific antibodies or CAR-T cell therapies.

Francesco Corrado, Nayda Bidikian, Anna Bosch, Yoshinobu Konishi et autres

0 citationsBlood

Accès ouvert 2025 conference-abstractOpenAlex

Real-world incidence and management of non-icans neurologic events following ciltacabtagene autoleucel in multiple myeloma

Doris K. Hansen, Omar Castañeda Puglianini, Ariel Grajales‐Cruz, Saurabh Nagar et autres

2 citationsBlood

Accès ouvert 2025 articleOpenAlex

Efficacy/Safety of Cilta-Cel ± Lenalidomide Maintenance in Patients With Multiple Myeloma Who Had Suboptimal Response to Frontline ASCT: Updated Follow-Up From CARTITUDE-2 Cohort D

Yaël C. Cohen, Tessa Kerre, Michel Delforge, María-Victoria Mateos et autres

1 citationClinical Lymphoma Myeloma & Leukemia

2025 conference-abstractOpenAlex

CO45 Systematic Review of Secondary Primary Malignancies (SPMs) in Patients Treated with Chimeric Antigen Receptor T-cell (CAR-T) Therapies

Mounzer Agha, Sarah McGregor, Kevin C. De Braganca, Tamar Lengil et autres

0 citationsValue in Health

2025 conference-abstractOpenAlex

CO204 Outcomes of Outpatient Administration of Ciltacabtagene Autoleucel (Cilta-Cel) in Relapsed Refractory Multiple Myeloma (RRMM)

Tara Gregory, Kevin C. De Braganca, Victoria R. Alegria, Matthew Perciavalle et autres

0 citationsValue in Health

Accès ouvert 2025 preprintOpenAlex

FORTRESS-CART: Focused Observation and Risk Testing for Robust Evaluation of Safety in Chimeric Antigen Receptor T-cell Therapy (CAR-T): Real-World Predictors of Second Primary Malignancies (SPMs) Among Patients Treated with CAR-T

Rafael Fonseca, Surbhi Sidana, Kevin C. De Braganca, Tamar Lengil et autres

0 citationsSSRN Electronic Journal

Accès ouvert 2025 preprintOpenAlex

Systematic literature review of secondary primary malignancies related to a CAR-T treatment in patients with multiple myeloma, lymphoma or leukemia

Mounzer Agha, Sarah McGregor, Kevin C. De Braganca, Tamar Lengil et autres

0 citationsSSRN Electronic Journal

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.